Skip to content
Home/Companies/MedTech/Gada
Gada

Gada

MedTech·Italy·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Gada?

Gada is currently owned by Principia SGR through Principia III - Health (2014 vintage), since 2018.

Hand-verified · updated 2026-07-26

Principia SGR
Investor
Principia SGR
Principia III - Health · 2014 · Life Sciences VC

Key facts

HQItaly
SectorMedTech
StatusActive
Websitegadaitalia.com

More from Principia III - Health

Other portfolio companies in the same fund.

Comftech
Active
MedTechItaly· 2018
Compass Pathways
Compass Pathways
Exited 2020
BiotechUK· 2018
CrestOptics
CrestOptics
Active
MedTechItaly· 2018
Enterome
Enterome
Active
BiotechFrance· 2018
Trifarma
Trifarma
Active
PharmaItaly· 2017
AnaBios
AnaBios
Active
BiotechUS· 2016

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Gada

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Gada?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Gada.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue